112 related articles for article (PubMed ID: 36621403)
1. Impact of pharmacist intervention to improve medication access for patients with diabetes.
Bias AA; Hiday RA; Kline MM
J Am Pharm Assoc (2003); 2023; 63(4S):S25-S30. PubMed ID: 36621403
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
Korcegez EI; Sancar M; Demirkan K
J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
[TBL] [Abstract][Full Text] [Related]
5. Evaluating a Pharmacist-Led Intervention on Cardiovascular- and Diabetes-Related Quality Measures in a Primary Care-Based Accountable Care Organization.
Joseph T; Hale G; Moreau C; Rosario ED; Logan N; Perez A
J Pharm Pract; 2022 Jun; 35(3):363-368. PubMed ID: 33302778
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home.
Prudencio J; Cutler T; Roberts S; Marin S; Wilson M
J Manag Care Spec Pharm; 2018 May; 24(5):423-429. PubMed ID: 29694290
[TBL] [Abstract][Full Text] [Related]
7. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Addition of Pharmacist Management to a Medication Assistance Program in Patients with Hypertension and Diabetes Resistant to Usual Care.
Smith AM; Hamann GL; Campbell JD; Sprabery LR
J Pharm Pract; 2022 Aug; 35(4):606-611. PubMed ID: 33739190
[TBL] [Abstract][Full Text] [Related]
9. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
Chung N; Rascati K; Lopez D; Jokerst J; Garza A
J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
[TBL] [Abstract][Full Text] [Related]
10. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction.
Kogut SJ; Johnson S; Higgins T; Quilliam B
J Manag Care Pharm; 2012 May; 18(4):297-310. PubMed ID: 22548690
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management "Tune Up" Clinic in Complex Patients.
Morello CM; Christopher ML; Ortega L; Khoan J; Rotunno T; Edelman SV; Henry RR; Hirsch JD
Ann Pharmacother; 2016 Jan; 50(1):8-16. PubMed ID: 26546580
[TBL] [Abstract][Full Text] [Related]
15. Optimization of Medication Use at Accountable Care Organizations.
Wilks C; Krisle E; Westrich K; Lunner K; Muhlestein D; Dubois R
J Manag Care Spec Pharm; 2017 Oct; 23(10):1054-1064. PubMed ID: 28944730
[TBL] [Abstract][Full Text] [Related]
16. Pharmacists' impact on improving outcomes in patients with type 2 diabetes mellitus.
Pepper MJ; Mallory N; Coker TN; Chaki A; Sando KR
Diabetes Educ; 2012; 38(3):409-16. PubMed ID: 22523190
[TBL] [Abstract][Full Text] [Related]
17. Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting.
Sullivan J; Jett BP; Cradick M; Zuber J
Ann Pharmacother; 2016 Dec; 50(12):1023-1027. PubMed ID: 27497068
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
19. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.
Fink RM; Mooney EV; Saseen JJ; Billups SJ
Pharm Pract (Granada); 2019; 17(4):1618. PubMed ID: 31897259
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
Salvo MC; Brooks AM
Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
